Sector Subsector Type of entity 3. Banking — Credit institutions referred to in point (1) of Article 4 of Regulation (EU) No 575/2013(57) 4. Financial market — Operators of trading venues infrastructures referred to in point (24) of Article 4 of Directive 2014/65/EU(58) — Central counterparties (CCPs) referred to in point (1) of Article 2 of Regulation (EU) No 648/2012(59) 5. Health — Healthcare providers referred to in point (g) of Article 3 of Directive 2011/24/EU(60) — EU reference laboratories referred to in Article 15 of Regulation XXXX/XXXX on serious crossborder threats to health61 57 58 59 60 61 Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 (OJ L 176, 27.6.2013, p. 1). Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (OJ L 173, 12.6.2014, p. 349). Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories (OJ L 201, 27.7.2012, p. 1). Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross–border healthcare (OJ L 88, 4.4.2011, p. 45). [Regulation of the European Parliament and of the Council on serious cross-border threats to health and repealing Decision No 1082/2013/EU, reference to be updated once the proposal COM (2020)727 final is adopted] 10193/22 ANNEXE EB/ip, pf JAI.2 LIMITE 162 FR/EN

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents